Brief: Annovis Bio Inc Announces Filing Of Patent
27/06/2023 12:50
June 27 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO INC - ANNOUNCES FILING OF A NEW COMPOSITION
OF
MATTER PROVISIONAL PATENT WITH U.S. PATENT AND TRADEMARK OFFICE
* ANNOVIS BIO INC - ANVS402 IS EXPECTED TO REPLACE
BUNTANETAP IN
FUTURE PD AND AD CLINICAL TRIALS AFTER COMPLETION OF A BRIDGING
STUDY IN EARLY 2024
Source text for Eikon: ID:nBwbcHZYta
Further company coverage: ANVS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman